FDA Proposes Drug Development Guidance for Rare Pediatric Diseases FDA Proposes Drug Development Guidance for Rare Pediatric Diseases

The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher ' s disease, by eliminating the need for certain trials and minimizing patient enrollment.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pediatrics News Source Type: news